- Home
- Publications
- Publication Search
- Publication Details
Title
ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 174, Issue 4, Pages R117-R126
Publisher
Bioscientifica
Online
2015-10-29
DOI
10.1530/eje-15-0605
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma
- (2015) G. Gandolfi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Coexistence of TERT Promoter and BRAF Mutations in Papillary Thyroid Carcinoma: Added Value in Patient Prognosis?
- (2015) Miguel Melo et al. JOURNAL OF CLINICAL ONCOLOGY
- Telomerase in differentiated thyroid cancer: Promoter mutations, expression and localization
- (2015) Marina Muzza et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
- (2015) R. J. A. Bell et al. SCIENCE
- Cancer-associated TERT promoter mutations abrogate telomerase silencing
- (2015) Kunitoshi Chiba et al. eLife
- Integrated Genomic Characterization of Papillary Thyroid Carcinoma
- (2014) Nishant Agrawal et al. CELL
- Cell Cycle Deregulation andTP53andRASMutations Are Major Events in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
- (2014) Jaime Miguel Pita et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- TERTPromoter Mutations and Their Association withBRAFV600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer
- (2014) Xiaoli Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
- (2014) Miguel Melo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- BRAF V600E and TERT Promoter Mutations Cooperatively Identify the Most Aggressive Papillary Thyroid Cancer With Highest Recurrence
- (2014) Mingzhao Xing et al. JOURNAL OF CLINICAL ONCOLOGY
- Noncoding RNAs in Endocrine Malignancy
- (2014) J. Kentwell et al. ONCOLOGIST
- PAX8/PPARγ Rearrangement in Thyroid Nodules Predicts Follicular-Pattern Carcinomas, in Particular the Encapsulated Follicular Variant of Papillary Carcinoma
- (2014) Michaele J. Armstrong et al. THYROID
- NRAS Codon 61 Mutation Is Associated with Distant Metastasis in Patients with Follicular Thyroid Carcinoma
- (2014) Eun Kyung Jang et al. THYROID
- Prognostic biomarkers in thyroid cancer
- (2014) Paula Soares et al. VIRCHOWS ARCHIV
- Highly prevalent TERT promoter mutations in aggressive thyroid cancers
- (2013) Xiaoli Liu et al. ENDOCRINE-RELATED CANCER
- Cribriform-Morular Variant of Papillary Thyroid Carcinoma Displaying Poorly Differentiated Features
- (2013) Tadao Nakazawa et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
- (2013) Mingzhao Xing et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Targeted Next-Generation Sequencing Panel (ThyroSeq) for Detection of Mutations in Thyroid Cancer
- (2013) Marina N. Nikiforova et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Frequent SomaticTERTPromoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease
- (2013) Iñigo Landa et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
- (2013) Alan L. Ho et al. NEW ENGLAND JOURNAL OF MEDICINE
- The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas
- (2013) T Liu et al. ONCOGENE
- RAS Mutations in Thyroid Cancer
- (2013) G. M. Howell et al. ONCOLOGIST
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Frequency of TERT promoter mutations in human cancers
- (2013) João Vinagre et al. Nature Communications
- A comparative study of cell cycle mediator protein expression patterns in anaplastic and papillary thyroid carcinoma
- (2012) Juanita J. Evans et al. CANCER BIOLOGY & THERAPY
- The biology and the genetics of Hürthle cell tumors of the thyroid
- (2012) Valdemar Máximo et al. ENDOCRINE-RELATED CANCER
- RET/PTCrearrangement is prevalent in follicular Hürthle cell carcinomas
- (2012) Margriet M de Vries et al. HISTOPATHOLOGY
- TheBRAFV600EMutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study
- (2012) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MicroRNA as a Diagnostic Tool in Fine-Needle Aspiration Biopsy of Thyroid Nodules
- (2012) H. Mazeh ONCOLOGIST
- The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type
- (2012) J. Jendrzejewski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Associations Between RAS Mutations and Clinical Characteristics in Follicular Thyroid Tumors: New Insights from a Single Center and a Large Patient Cohort
- (2012) Michiko Fukahori et al. THYROID
- TGF-beta/Smad pathway and BRAF mutation play different roles in circumscribed and infiltrative papillary thyroid carcinoma
- (2012) C. Eloy et al. VIRCHOWS ARCHIV
- RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma
- (2012) Cristina Romei et al. Frontiers in Endocrinology
- Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
- (2011) Paula Soares et al. CURRENT GENOMICS
- Telomere Length in Neoplastic and Nonneoplastic Tissues of Patients with Familial and Sporadic Papillary Thyroid Cancer
- (2011) Marco Capezzone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
- (2011) Debyani Chakravarty et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular genetics and diagnosis of thyroid cancer
- (2011) Yuri E. Nikiforov et al. Nature Reviews Endocrinology
- The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases
- (2011) Catarina Eloy et al. VIRCHOWS ARCHIV
- RET rearrangements and BRAF mutation in undifferentiated thyroid carcinomas having papillary carcinoma components
- (2010) Kunio Mochizuki et al. HISTOPATHOLOGY
- p53 Research: The Past Thirty Years and the Next Thirty Years
- (2010) D. Lane et al. Cold Spring Harbor Perspectives in Biology
- High prevalence ofBRAFmutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas
- (2009) Gisele Oler et al. CANCER
- Cribriform-Morular Variant of Papillary Thyroid Carcinoma
- (2008) José Cameselle-Teijeiro et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer
- (2008) C. Romei et al. ENDOCRINE-RELATED CANCER
- Intragenic Mutations in Thyroid Cancer
- (2008) Manuel Sobrinho-Simões et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- BRAFV600EMutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
- (2008) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now